logologo

close

COPYRIGHT 2020 POSVAX CO. LTD. ALL RIGHTS RESERVED.

r&d

Prophylactic Vaccines

RSV Vaccines

baby

Respiratory syncytial virus (RSV) is a virus causing rapid respiratory infection to people with low immunity including infants and the elderly. To infants, it can cause bronchitis and pneumonia, and even to death.

Process of pneumonia
pneumonia
RSV VaccinesHighlights

POSVAX RSV
VACCINES

FEATURES
  • VLP-based prophylactic
    vaccines
  • Excellent immunogenicity
    and safety
STATE OF
DEVELOPMENT
  • VLP manufacturing
    process developed
EFFICACY
  • Prevent bronchitis and
    pneumonia
  • Decrease hospitalization
    and death rates of infants
FUTURE
MARKET
  • VLP based RSV vaccine is highly
    potential vaccine platform
  • Grow to about $1.5 bil. of new
    potential market